0001761882-24-000002.txt : 20241010 0001761882-24-000002.hdr.sgml : 20241010 20241010142653 ACCESSION NUMBER: 0001761882-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241010 DATE AS OF CHANGE: 20241010 EFFECTIVENESS DATE: 20241010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vantis Vascular, Inc. CENTRAL INDEX KEY: 0001761882 ORGANIZATION NAME: IRS NUMBER: 823343057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-526461 FILM NUMBER: 241364837 BUSINESS ADDRESS: STREET 1: 2348 SHEFFIELD DRIVE CITY: KALAMAZOO STATE: MI ZIP: 49008 BUSINESS PHONE: 269-352-4766 MAIL ADDRESS: STREET 1: 2348 SHEFFIELD DRIVE CITY: KALAMAZOO STATE: MI ZIP: 49008 FORMER COMPANY: FORMER CONFORMED NAME: CrossLiner, Inc. DATE OF NAME CHANGE: 20181214 D 1 primary_doc.xml X0708 D LIVE 0001761882 Vantis Vascular, Inc. 2570 N First Street Suite 200 San Jose CA CALIFORNIA 95131 269-337-7700 DELAWARE CrossLiner, Inc. Corporation true Tim Fischell c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Director Frank Saltiel c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Director Len Pinchuk c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Director Jason Turner c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Director Marc Monahan c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Mike Mirizzi c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Gary McCord c/o Vantis Vascular, Inc. 2570 N First Street, Suite 200 San Jose CA CALIFORNIA 95131 Executive Officer Other Decline to Disclose 06b false 2024-09-30 false true false 0 22199202 14338798 7860404 Of the total amount sold, $2,881,011 relates to new money investments, $4,967,639 relates to shares issued for the conversion of SAFEs, and $6,490,148 relates to shares issued in exchange for another series of shares. false 114 0 0 0 false Vantis Vascular, Inc. /s/ Phillip Torrence Phillip Torrence Secretary 2024-10-10